2. UroToday Home
  3. Recent Abstracts
  4. Urologic Oncology
  5. Prostate Cancer

Comparison of Post-Therapy 4 and 24-hour [177Lu]Lu-PSMA SPECT/CT and Pre-Therapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castrate-Resistant Prostate Cancer.

Comparison of Posttherapy 4 and 24-Hour [177Lu]Lu-PSMA SPECT/CT and Pretherapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant Prostate Cancer - Beyond the Abstract

Click here to view Beyond the Abstract Slides:


Mina Swiha, MD, PhD, St. Vincent Hospital, Sydney, Australia